Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Axoltis misses the mark in phase 2 ALS study but still strives to move towards the clinic
Biotech

Axoltis misses the mark in phase 2 ALS study

The French biotech will continue to develop its leading synthetic peptide, NX210c, for clinical development.
Marissa Russo Sep 15, 2026 3:00am
psychedelic brain think thought hallucinogenic psychology

FDA holds psychedelic hearing as historic approval looms

Sep 14, 2026 6:00pm
The signal that changes everything understanding MRD in oncology drug development

The signal that changes everything: understanding MRD in oncology drug development

Brought to you by Natera
Person throwing piece of paper into full waste bin

Lilly cans early obesity drug after ‘high bar’ not met

Sep 14, 2026 12:45pm
Moving NAMs from Progress to Practice Building the Foundation for Broader Adoption

Moving NAMs from Progress to Practice

Brought to you by Battelle
Completing steps towards success checkmark on cubes symbolizing progress

Corbus posts obesity data in area where Novo, Sanofi stumbled

Sep 14, 2026 10:07am